nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—CYP2D6—Fingolimod—multiple sclerosis	0.108	0.148	CbGbCtD
Reboxetine—ABCB1—Methylprednisolone—multiple sclerosis	0.0742	0.101	CbGbCtD
Reboxetine—CYP3A4—Fingolimod—multiple sclerosis	0.069	0.0938	CbGbCtD
Reboxetine—ABCB1—Mitoxantrone—multiple sclerosis	0.0541	0.0736	CbGbCtD
Reboxetine—ABCB1—Betamethasone—multiple sclerosis	0.0482	0.0656	CbGbCtD
Reboxetine—ABCB1—Prednisolone—multiple sclerosis	0.0476	0.0647	CbGbCtD
Reboxetine—ABCB1—Prednisone—multiple sclerosis	0.0449	0.0611	CbGbCtD
Reboxetine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0444	0.0605	CbGbCtD
Reboxetine—CYP3A4—Triamcinolone—multiple sclerosis	0.0337	0.0458	CbGbCtD
Reboxetine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0324	0.0441	CbGbCtD
Reboxetine—CYP3A4—Betamethasone—multiple sclerosis	0.0289	0.0393	CbGbCtD
Reboxetine—CYP3A4—Prednisolone—multiple sclerosis	0.0285	0.0388	CbGbCtD
Reboxetine—ABCB1—Dexamethasone—multiple sclerosis	0.0281	0.0382	CbGbCtD
Reboxetine—CYP3A4—Prednisone—multiple sclerosis	0.0269	0.0366	CbGbCtD
Reboxetine—CYP2D6—Dexamethasone—multiple sclerosis	0.0264	0.036	CbGbCtD
Reboxetine—ABCB1—Methotrexate—multiple sclerosis	0.0225	0.0307	CbGbCtD
Reboxetine—CYP3A4—Dexamethasone—multiple sclerosis	0.0168	0.0229	CbGbCtD
Reboxetine—SLC6A2—nerve—multiple sclerosis	0.00105	0.123	CbGeAlD
Reboxetine—HTR2C—brainstem—multiple sclerosis	0.000538	0.0631	CbGeAlD
Reboxetine—SLC6A4—brainstem—multiple sclerosis	0.00051	0.0599	CbGeAlD
Reboxetine—SLC6A2—brainstem—multiple sclerosis	0.000449	0.0527	CbGeAlD
Reboxetine—HTR2C—medulla oblongata—multiple sclerosis	0.000375	0.044	CbGeAlD
Reboxetine—HTR2C—midbrain—multiple sclerosis	0.000343	0.0402	CbGeAlD
Reboxetine—HTR2C—spinal cord—multiple sclerosis	0.000334	0.0393	CbGeAlD
Reboxetine—Connective tissue disorder—Prednisone—multiple sclerosis	0.000327	0.00128	CcSEcCtD
Reboxetine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000327	0.00128	CcSEcCtD
Reboxetine—SLC6A4—midbrain—multiple sclerosis	0.000325	0.0381	CbGeAlD
Reboxetine—Dysuria—Methotrexate—multiple sclerosis	0.000325	0.00127	CcSEcCtD
Reboxetine—Dizziness—Azathioprine—multiple sclerosis	0.000324	0.00127	CcSEcCtD
Reboxetine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000324	0.00127	CcSEcCtD
Reboxetine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000322	0.00126	CcSEcCtD
Reboxetine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000322	0.00125	CcSEcCtD
Reboxetine—Shock—Prednisolone—multiple sclerosis	0.00032	0.00125	CcSEcCtD
Reboxetine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00032	0.00125	CcSEcCtD
Reboxetine—Tachycardia—Prednisolone—multiple sclerosis	0.000318	0.00124	CcSEcCtD
Reboxetine—SLC6A4—spinal cord—multiple sclerosis	0.000317	0.0372	CbGeAlD
Reboxetine—Hypertension—Triamcinolone—multiple sclerosis	0.000317	0.00124	CcSEcCtD
Reboxetine—Hypertension—Methylprednisolone—multiple sclerosis	0.000316	0.00123	CcSEcCtD
Reboxetine—Urticaria—Mitoxantrone—multiple sclerosis	0.000315	0.00123	CcSEcCtD
Reboxetine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000315	0.00123	CcSEcCtD
Reboxetine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000314	0.00122	CcSEcCtD
Reboxetine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000314	0.00122	CcSEcCtD
Reboxetine—SLC6A2—medulla oblongata—multiple sclerosis	0.000313	0.0367	CbGeAlD
Reboxetine—Vomiting—Azathioprine—multiple sclerosis	0.000312	0.00122	CcSEcCtD
Reboxetine—Eye disorder—Prednisone—multiple sclerosis	0.000311	0.00121	CcSEcCtD
Reboxetine—Anxiety—Methylprednisolone—multiple sclerosis	0.00031	0.00121	CcSEcCtD
Reboxetine—Infestation NOS—Methotrexate—multiple sclerosis	0.00031	0.00121	CcSEcCtD
Reboxetine—Infestation—Methotrexate—multiple sclerosis	0.00031	0.00121	CcSEcCtD
Reboxetine—Rash—Azathioprine—multiple sclerosis	0.000309	0.00121	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000309	0.00121	CcSEcCtD
Reboxetine—Dermatitis—Azathioprine—multiple sclerosis	0.000309	0.00121	CcSEcCtD
Reboxetine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000309	0.0012	CcSEcCtD
Reboxetine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000309	0.0012	CcSEcCtD
Reboxetine—Discomfort—Triamcinolone—multiple sclerosis	0.000308	0.0012	CcSEcCtD
Reboxetine—Discomfort—Methylprednisolone—multiple sclerosis	0.000308	0.0012	CcSEcCtD
Reboxetine—Headache—Azathioprine—multiple sclerosis	0.000307	0.0012	CcSEcCtD
Reboxetine—Dry mouth—Triamcinolone—multiple sclerosis	0.000305	0.00119	CcSEcCtD
Reboxetine—Angiopathy—Prednisone—multiple sclerosis	0.000302	0.00118	CcSEcCtD
Reboxetine—Conjunctivitis—Methotrexate—multiple sclerosis	0.000301	0.00118	CcSEcCtD
Reboxetine—Confusional state—Methylprednisolone—multiple sclerosis	0.000301	0.00117	CcSEcCtD
Reboxetine—Immune system disorder—Prednisone—multiple sclerosis	0.000301	0.00117	CcSEcCtD
Reboxetine—Malaise—Dexamethasone—multiple sclerosis	0.0003	0.00117	CcSEcCtD
Reboxetine—Malaise—Betamethasone—multiple sclerosis	0.0003	0.00117	CcSEcCtD
Reboxetine—Vertigo—Dexamethasone—multiple sclerosis	0.000299	0.00117	CcSEcCtD
Reboxetine—Vertigo—Betamethasone—multiple sclerosis	0.000299	0.00117	CcSEcCtD
Reboxetine—Syncope—Dexamethasone—multiple sclerosis	0.000298	0.00116	CcSEcCtD
Reboxetine—Syncope—Betamethasone—multiple sclerosis	0.000298	0.00116	CcSEcCtD
Reboxetine—Infection—Triamcinolone—multiple sclerosis	0.000297	0.00116	CcSEcCtD
Reboxetine—Sweating—Methotrexate—multiple sclerosis	0.000297	0.00116	CcSEcCtD
Reboxetine—Infection—Methylprednisolone—multiple sclerosis	0.000297	0.00116	CcSEcCtD
Reboxetine—Shock—Triamcinolone—multiple sclerosis	0.000294	0.00115	CcSEcCtD
Reboxetine—Insomnia—Prednisolone—multiple sclerosis	0.000294	0.00115	CcSEcCtD
Reboxetine—Shock—Methylprednisolone—multiple sclerosis	0.000294	0.00115	CcSEcCtD
Reboxetine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000293	0.00114	CcSEcCtD
Reboxetine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000292	0.00114	CcSEcCtD
Reboxetine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000292	0.00114	CcSEcCtD
Reboxetine—Epistaxis—Methotrexate—multiple sclerosis	0.000292	0.00114	CcSEcCtD
Reboxetine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000292	0.00114	CcSEcCtD
Reboxetine—Paraesthesia—Prednisolone—multiple sclerosis	0.000292	0.00114	CcSEcCtD
Reboxetine—Tachycardia—Triamcinolone—multiple sclerosis	0.000292	0.00114	CcSEcCtD
Reboxetine—Mental disorder—Prednisone—multiple sclerosis	0.000292	0.00114	CcSEcCtD
Reboxetine—Nausea—Azathioprine—multiple sclerosis	0.000291	0.00114	CcSEcCtD
Reboxetine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000291	0.00114	CcSEcCtD
Reboxetine—Skin disorder—Methylprednisolone—multiple sclerosis	0.00029	0.00113	CcSEcCtD
Reboxetine—Malnutrition—Prednisone—multiple sclerosis	0.00029	0.00113	CcSEcCtD
Reboxetine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000289	0.00113	CcSEcCtD
Reboxetine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000289	0.00113	CcSEcCtD
Reboxetine—Hypertension—Betamethasone—multiple sclerosis	0.000287	0.00112	CcSEcCtD
Reboxetine—Hypertension—Dexamethasone—multiple sclerosis	0.000287	0.00112	CcSEcCtD
Reboxetine—Asthenia—Mitoxantrone—multiple sclerosis	0.000285	0.00111	CcSEcCtD
Reboxetine—Anxiety—Dexamethasone—multiple sclerosis	0.000282	0.0011	CcSEcCtD
Reboxetine—Anxiety—Betamethasone—multiple sclerosis	0.000282	0.0011	CcSEcCtD
Reboxetine—HTR2C—nervous system—multiple sclerosis	0.000282	0.0331	CbGeAlD
Reboxetine—Discomfort—Dexamethasone—multiple sclerosis	0.00028	0.00109	CcSEcCtD
Reboxetine—Discomfort—Betamethasone—multiple sclerosis	0.00028	0.00109	CcSEcCtD
Reboxetine—Hypotension—Methylprednisolone—multiple sclerosis	0.000279	0.00109	CcSEcCtD
Reboxetine—Pharyngitis—Methotrexate—multiple sclerosis	0.000276	0.00108	CcSEcCtD
Reboxetine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000275	0.00107	CcSEcCtD
Reboxetine—Urethral disorder—Methotrexate—multiple sclerosis	0.000273	0.00106	CcSEcCtD
Reboxetine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000271	0.00106	CcSEcCtD
Reboxetine—HTR2C—central nervous system—multiple sclerosis	0.000271	0.0319	CbGeAlD
Reboxetine—Insomnia—Triamcinolone—multiple sclerosis	0.000271	0.00106	CcSEcCtD
Reboxetine—Insomnia—Methylprednisolone—multiple sclerosis	0.00027	0.00105	CcSEcCtD
Reboxetine—Infection—Betamethasone—multiple sclerosis	0.00027	0.00105	CcSEcCtD
Reboxetine—Infection—Dexamethasone—multiple sclerosis	0.00027	0.00105	CcSEcCtD
Reboxetine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000269	0.00105	CcSEcCtD
Reboxetine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000269	0.00105	CcSEcCtD
Reboxetine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000268	0.00105	CcSEcCtD
Reboxetine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000268	0.00105	CcSEcCtD
Reboxetine—Visual impairment—Methotrexate—multiple sclerosis	0.000268	0.00105	CcSEcCtD
Reboxetine—Anaemia—Prednisone—multiple sclerosis	0.000268	0.00104	CcSEcCtD
Reboxetine—SLC6A4—nervous system—multiple sclerosis	0.000267	0.0314	CbGeAlD
Reboxetine—Shock—Betamethasone—multiple sclerosis	0.000267	0.00104	CcSEcCtD
Reboxetine—Shock—Dexamethasone—multiple sclerosis	0.000267	0.00104	CcSEcCtD
Reboxetine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000267	0.00104	CcSEcCtD
Reboxetine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000266	0.00104	CcSEcCtD
Reboxetine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000266	0.00104	CcSEcCtD
Reboxetine—Agitation—Prednisone—multiple sclerosis	0.000266	0.00104	CcSEcCtD
Reboxetine—Tachycardia—Betamethasone—multiple sclerosis	0.000265	0.00103	CcSEcCtD
Reboxetine—Tachycardia—Dexamethasone—multiple sclerosis	0.000265	0.00103	CcSEcCtD
Reboxetine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000263	0.00103	CcSEcCtD
Reboxetine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000263	0.00103	CcSEcCtD
Reboxetine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000262	0.00102	CcSEcCtD
Reboxetine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000262	0.00102	CcSEcCtD
Reboxetine—Malaise—Prednisone—multiple sclerosis	0.000261	0.00102	CcSEcCtD
Reboxetine—Vertigo—Prednisone—multiple sclerosis	0.00026	0.00102	CcSEcCtD
Reboxetine—Eye disorder—Methotrexate—multiple sclerosis	0.00026	0.00101	CcSEcCtD
Reboxetine—Syncope—Prednisone—multiple sclerosis	0.00026	0.00101	CcSEcCtD
Reboxetine—Tinnitus—Methotrexate—multiple sclerosis	0.000259	0.00101	CcSEcCtD
Reboxetine—Anorexia—Dexamethasone—multiple sclerosis	0.000259	0.00101	CcSEcCtD
Reboxetine—Anorexia—Betamethasone—multiple sclerosis	0.000259	0.00101	CcSEcCtD
Reboxetine—Urticaria—Prednisolone—multiple sclerosis	0.000259	0.00101	CcSEcCtD
Reboxetine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000258	0.00101	CcSEcCtD
Reboxetine—SLC6A4—central nervous system—multiple sclerosis	0.000257	0.0302	CbGeAlD
Reboxetine—Loss of consciousness—Prednisone—multiple sclerosis	0.000255	0.000994	CcSEcCtD
Reboxetine—Hypotension—Betamethasone—multiple sclerosis	0.000254	0.00099	CcSEcCtD
Reboxetine—Hypotension—Dexamethasone—multiple sclerosis	0.000254	0.00099	CcSEcCtD
Reboxetine—Angiopathy—Methotrexate—multiple sclerosis	0.000252	0.000985	CcSEcCtD
Reboxetine—Vomiting—Mitoxantrone—multiple sclerosis	0.000252	0.000984	CcSEcCtD
Reboxetine—Immune system disorder—Methotrexate—multiple sclerosis	0.000251	0.00098	CcSEcCtD
Reboxetine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000251	0.000978	CcSEcCtD
Reboxetine—Hypertension—Prednisone—multiple sclerosis	0.00025	0.000976	CcSEcCtD
Reboxetine—Rash—Mitoxantrone—multiple sclerosis	0.00025	0.000976	CcSEcCtD
Reboxetine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00025	0.000975	CcSEcCtD
Reboxetine—Chills—Methotrexate—multiple sclerosis	0.00025	0.000974	CcSEcCtD
Reboxetine—Headache—Mitoxantrone—multiple sclerosis	0.000248	0.00097	CcSEcCtD
Reboxetine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000247	0.000962	CcSEcCtD
Reboxetine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000246	0.00096	CcSEcCtD
Reboxetine—CYP2D6—brainstem—multiple sclerosis	0.000246	0.0289	CbGeAlD
Reboxetine—Anxiety—Prednisone—multiple sclerosis	0.000246	0.000959	CcSEcCtD
Reboxetine—Insomnia—Betamethasone—multiple sclerosis	0.000246	0.000958	CcSEcCtD
Reboxetine—Insomnia—Dexamethasone—multiple sclerosis	0.000246	0.000958	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000245	0.000956	CcSEcCtD
Reboxetine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000244	0.000953	CcSEcCtD
Reboxetine—Paraesthesia—Betamethasone—multiple sclerosis	0.000244	0.000951	CcSEcCtD
Reboxetine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000244	0.000951	CcSEcCtD
Reboxetine—Discomfort—Prednisone—multiple sclerosis	0.000244	0.000951	CcSEcCtD
Reboxetine—Mental disorder—Methotrexate—multiple sclerosis	0.000244	0.000951	CcSEcCtD
Reboxetine—Malnutrition—Methotrexate—multiple sclerosis	0.000242	0.000945	CcSEcCtD
Reboxetine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00024	0.000935	CcSEcCtD
Reboxetine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000239	0.000933	CcSEcCtD
Reboxetine—Dyspepsia—Betamethasone—multiple sclerosis	0.000239	0.000933	CcSEcCtD
Reboxetine—Urticaria—Triamcinolone—multiple sclerosis	0.000238	0.000928	CcSEcCtD
Reboxetine—Urticaria—Methylprednisolone—multiple sclerosis	0.000237	0.000926	CcSEcCtD
Reboxetine—Dysgeusia—Methotrexate—multiple sclerosis	0.000237	0.000925	CcSEcCtD
Reboxetine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000237	0.000923	CcSEcCtD
Reboxetine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000236	0.000921	CcSEcCtD
Reboxetine—Decreased appetite—Betamethasone—multiple sclerosis	0.000236	0.000921	CcSEcCtD
Reboxetine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000236	0.000921	CcSEcCtD
Reboxetine—Nausea—Mitoxantrone—multiple sclerosis	0.000236	0.000919	CcSEcCtD
Reboxetine—SLC6A2—nervous system—multiple sclerosis	0.000235	0.0276	CbGeAlD
Reboxetine—Infection—Prednisone—multiple sclerosis	0.000235	0.000917	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000234	0.000915	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000234	0.000915	CcSEcCtD
Reboxetine—Shock—Prednisone—multiple sclerosis	0.000233	0.000908	CcSEcCtD
Reboxetine—Nervous system disorder—Prednisone—multiple sclerosis	0.000232	0.000905	CcSEcCtD
Reboxetine—Tachycardia—Prednisone—multiple sclerosis	0.000231	0.000901	CcSEcCtD
Reboxetine—Skin disorder—Prednisone—multiple sclerosis	0.00023	0.000896	CcSEcCtD
Reboxetine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000229	0.000892	CcSEcCtD
Reboxetine—SLC6A2—central nervous system—multiple sclerosis	0.000226	0.0266	CbGeAlD
Reboxetine—Anorexia—Prednisone—multiple sclerosis	0.000225	0.000879	CcSEcCtD
Reboxetine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000225	0.000877	CcSEcCtD
Reboxetine—Anaemia—Methotrexate—multiple sclerosis	0.000224	0.000873	CcSEcCtD
Reboxetine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000224	0.000873	CcSEcCtD
Reboxetine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000224	0.000873	CcSEcCtD
Reboxetine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000222	0.000866	CcSEcCtD
Reboxetine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000222	0.000866	CcSEcCtD
Reboxetine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00022	0.00086	CcSEcCtD
Reboxetine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00022	0.000858	CcSEcCtD
Reboxetine—Malaise—Methotrexate—multiple sclerosis	0.000218	0.000852	CcSEcCtD
Reboxetine—Vertigo—Methotrexate—multiple sclerosis	0.000218	0.000849	CcSEcCtD
Reboxetine—Leukopenia—Methotrexate—multiple sclerosis	0.000217	0.000846	CcSEcCtD
Reboxetine—Urticaria—Betamethasone—multiple sclerosis	0.000216	0.000842	CcSEcCtD
Reboxetine—Urticaria—Dexamethasone—multiple sclerosis	0.000216	0.000842	CcSEcCtD
Reboxetine—HTR2C—brain—multiple sclerosis	0.000215	0.0253	CbGeAlD
Reboxetine—Dizziness—Prednisolone—multiple sclerosis	0.000215	0.00084	CcSEcCtD
Reboxetine—Asthenia—Triamcinolone—multiple sclerosis	0.000215	0.000838	CcSEcCtD
Reboxetine—Abdominal pain—Betamethasone—multiple sclerosis	0.000215	0.000838	CcSEcCtD
Reboxetine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000215	0.000838	CcSEcCtD
Reboxetine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000215	0.000838	CcSEcCtD
Reboxetine—Body temperature increased—Betamethasone—multiple sclerosis	0.000215	0.000838	CcSEcCtD
Reboxetine—Asthenia—Methylprednisolone—multiple sclerosis	0.000214	0.000836	CcSEcCtD
Reboxetine—Insomnia—Prednisone—multiple sclerosis	0.000214	0.000835	CcSEcCtD
Reboxetine—Paraesthesia—Prednisone—multiple sclerosis	0.000212	0.000829	CcSEcCtD
Reboxetine—Dyspepsia—Prednisone—multiple sclerosis	0.000208	0.000812	CcSEcCtD
Reboxetine—Chest pain—Methotrexate—multiple sclerosis	0.000206	0.000804	CcSEcCtD
Reboxetine—Decreased appetite—Prednisone—multiple sclerosis	0.000206	0.000802	CcSEcCtD
Reboxetine—Rash—Prednisolone—multiple sclerosis	0.000205	0.000801	CcSEcCtD
Reboxetine—Dermatitis—Prednisolone—multiple sclerosis	0.000205	0.0008	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000205	0.000799	CcSEcCtD
Reboxetine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000204	0.000797	CcSEcCtD
Reboxetine—SLC6A4—brain—multiple sclerosis	0.000204	0.024	CbGeAlD
Reboxetine—Headache—Prednisolone—multiple sclerosis	0.000204	0.000795	CcSEcCtD
Reboxetine—Discomfort—Methotrexate—multiple sclerosis	0.000204	0.000795	CcSEcCtD
Reboxetine—Constipation—Prednisone—multiple sclerosis	0.000202	0.000789	CcSEcCtD
Reboxetine—Confusional state—Methotrexate—multiple sclerosis	0.000199	0.000778	CcSEcCtD
Reboxetine—Dizziness—Triamcinolone—multiple sclerosis	0.000198	0.000772	CcSEcCtD
Reboxetine—Dizziness—Methylprednisolone—multiple sclerosis	0.000197	0.00077	CcSEcCtD
Reboxetine—Infection—Methotrexate—multiple sclerosis	0.000196	0.000766	CcSEcCtD
Reboxetine—Feeling abnormal—Prednisone—multiple sclerosis	0.000195	0.00076	CcSEcCtD
Reboxetine—Asthenia—Dexamethasone—multiple sclerosis	0.000195	0.00076	CcSEcCtD
Reboxetine—Asthenia—Betamethasone—multiple sclerosis	0.000195	0.00076	CcSEcCtD
Reboxetine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000194	0.000756	CcSEcCtD
Reboxetine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000193	0.000754	CcSEcCtD
Reboxetine—Nausea—Prednisolone—multiple sclerosis	0.000193	0.000754	CcSEcCtD
Reboxetine—Skin disorder—Methotrexate—multiple sclerosis	0.000192	0.000749	CcSEcCtD
Reboxetine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000191	0.000745	CcSEcCtD
Reboxetine—Vomiting—Triamcinolone—multiple sclerosis	0.00019	0.000742	CcSEcCtD
Reboxetine—Vomiting—Methylprednisolone—multiple sclerosis	0.00019	0.000741	CcSEcCtD
Reboxetine—Rash—Triamcinolone—multiple sclerosis	0.000189	0.000736	CcSEcCtD
Reboxetine—Dermatitis—Triamcinolone—multiple sclerosis	0.000189	0.000736	CcSEcCtD
Reboxetine—Anorexia—Methotrexate—multiple sclerosis	0.000188	0.000735	CcSEcCtD
Reboxetine—Rash—Methylprednisolone—multiple sclerosis	0.000188	0.000735	CcSEcCtD
Reboxetine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000188	0.000734	CcSEcCtD
Reboxetine—Urticaria—Prednisone—multiple sclerosis	0.000188	0.000733	CcSEcCtD
Reboxetine—Headache—Triamcinolone—multiple sclerosis	0.000187	0.000731	CcSEcCtD
Reboxetine—Headache—Methylprednisolone—multiple sclerosis	0.000187	0.00073	CcSEcCtD
Reboxetine—Body temperature increased—Prednisone—multiple sclerosis	0.000187	0.000729	CcSEcCtD
Reboxetine—Abdominal pain—Prednisone—multiple sclerosis	0.000187	0.000729	CcSEcCtD
Reboxetine—Diarrhoea—Betamethasone—multiple sclerosis	0.000186	0.000725	CcSEcCtD
Reboxetine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000186	0.000725	CcSEcCtD
Reboxetine—Hypotension—Methotrexate—multiple sclerosis	0.000185	0.000721	CcSEcCtD
Reboxetine—SLC6A2—brain—multiple sclerosis	0.00018	0.0211	CbGeAlD
Reboxetine—Dizziness—Dexamethasone—multiple sclerosis	0.00018	0.000701	CcSEcCtD
Reboxetine—Dizziness—Betamethasone—multiple sclerosis	0.00018	0.000701	CcSEcCtD
Reboxetine—Insomnia—Methotrexate—multiple sclerosis	0.000179	0.000697	CcSEcCtD
Reboxetine—Nausea—Triamcinolone—multiple sclerosis	0.000178	0.000694	CcSEcCtD
Reboxetine—Paraesthesia—Methotrexate—multiple sclerosis	0.000177	0.000692	CcSEcCtD
Reboxetine—Nausea—Methylprednisolone—multiple sclerosis	0.000177	0.000692	CcSEcCtD
Reboxetine—Dyspnoea—Methotrexate—multiple sclerosis	0.000176	0.000687	CcSEcCtD
Reboxetine—Somnolence—Methotrexate—multiple sclerosis	0.000176	0.000686	CcSEcCtD
Reboxetine—Hypersensitivity—Prednisone—multiple sclerosis	0.000174	0.00068	CcSEcCtD
Reboxetine—Dyspepsia—Methotrexate—multiple sclerosis	0.000174	0.000679	CcSEcCtD
Reboxetine—Vomiting—Dexamethasone—multiple sclerosis	0.000173	0.000674	CcSEcCtD
Reboxetine—Vomiting—Betamethasone—multiple sclerosis	0.000173	0.000674	CcSEcCtD
Reboxetine—Decreased appetite—Methotrexate—multiple sclerosis	0.000172	0.00067	CcSEcCtD
Reboxetine—Rash—Dexamethasone—multiple sclerosis	0.000171	0.000668	CcSEcCtD
Reboxetine—Rash—Betamethasone—multiple sclerosis	0.000171	0.000668	CcSEcCtD
Reboxetine—Dermatitis—Dexamethasone—multiple sclerosis	0.000171	0.000667	CcSEcCtD
Reboxetine—Dermatitis—Betamethasone—multiple sclerosis	0.000171	0.000667	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000171	0.000666	CcSEcCtD
Reboxetine—ABCB1—retina—multiple sclerosis	0.000171	0.02	CbGeAlD
Reboxetine—Headache—Betamethasone—multiple sclerosis	0.00017	0.000664	CcSEcCtD
Reboxetine—Headache—Dexamethasone—multiple sclerosis	0.00017	0.000664	CcSEcCtD
Reboxetine—Asthenia—Prednisone—multiple sclerosis	0.00017	0.000662	CcSEcCtD
Reboxetine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000163	0.000635	CcSEcCtD
Reboxetine—Diarrhoea—Prednisone—multiple sclerosis	0.000162	0.000631	CcSEcCtD
Reboxetine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000162	0.000631	CcSEcCtD
Reboxetine—Nausea—Betamethasone—multiple sclerosis	0.000161	0.000629	CcSEcCtD
Reboxetine—Nausea—Dexamethasone—multiple sclerosis	0.000161	0.000629	CcSEcCtD
Reboxetine—Urticaria—Methotrexate—multiple sclerosis	0.000157	0.000613	CcSEcCtD
Reboxetine—Dizziness—Prednisone—multiple sclerosis	0.000156	0.00061	CcSEcCtD
Reboxetine—Body temperature increased—Methotrexate—multiple sclerosis	0.000156	0.00061	CcSEcCtD
Reboxetine—Abdominal pain—Methotrexate—multiple sclerosis	0.000156	0.00061	CcSEcCtD
Reboxetine—Vomiting—Prednisone—multiple sclerosis	0.00015	0.000587	CcSEcCtD
Reboxetine—Rash—Prednisone—multiple sclerosis	0.000149	0.000582	CcSEcCtD
Reboxetine—Dermatitis—Prednisone—multiple sclerosis	0.000149	0.000581	CcSEcCtD
Reboxetine—Headache—Prednisone—multiple sclerosis	0.000148	0.000578	CcSEcCtD
Reboxetine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000146	0.000568	CcSEcCtD
Reboxetine—Asthenia—Methotrexate—multiple sclerosis	0.000142	0.000553	CcSEcCtD
Reboxetine—Nausea—Prednisone—multiple sclerosis	0.00014	0.000548	CcSEcCtD
Reboxetine—Diarrhoea—Methotrexate—multiple sclerosis	0.000135	0.000528	CcSEcCtD
Reboxetine—CYP3A4—nervous system—multiple sclerosis	0.000131	0.0154	CbGeAlD
Reboxetine—Dizziness—Methotrexate—multiple sclerosis	0.000131	0.00051	CcSEcCtD
Reboxetine—CYP2D6—nervous system—multiple sclerosis	0.000129	0.0151	CbGeAlD
Reboxetine—CYP3A4—central nervous system—multiple sclerosis	0.000126	0.0148	CbGeAlD
Reboxetine—Vomiting—Methotrexate—multiple sclerosis	0.000126	0.00049	CcSEcCtD
Reboxetine—Rash—Methotrexate—multiple sclerosis	0.000125	0.000486	CcSEcCtD
Reboxetine—Dermatitis—Methotrexate—multiple sclerosis	0.000124	0.000486	CcSEcCtD
Reboxetine—CYP2D6—central nervous system—multiple sclerosis	0.000124	0.0146	CbGeAlD
Reboxetine—Headache—Methotrexate—multiple sclerosis	0.000124	0.000483	CcSEcCtD
Reboxetine—ABCB1—medulla oblongata—multiple sclerosis	0.000123	0.0145	CbGeAlD
Reboxetine—CYP2D6—cerebellum—multiple sclerosis	0.000121	0.0142	CbGeAlD
Reboxetine—Nausea—Methotrexate—multiple sclerosis	0.000117	0.000458	CcSEcCtD
Reboxetine—ABCB1—midbrain—multiple sclerosis	0.000113	0.0132	CbGeAlD
Reboxetine—ABCB1—spinal cord—multiple sclerosis	0.00011	0.0129	CbGeAlD
Reboxetine—CYP2D6—brain—multiple sclerosis	9.84e-05	0.0116	CbGeAlD
Reboxetine—ABCB1—nervous system—multiple sclerosis	9.27e-05	0.0109	CbGeAlD
Reboxetine—ABCB1—central nervous system—multiple sclerosis	8.92e-05	0.0105	CbGeAlD
Reboxetine—ABCB1—cerebellum—multiple sclerosis	8.72e-05	0.0102	CbGeAlD
Reboxetine—ABCB1—brain—multiple sclerosis	7.08e-05	0.00831	CbGeAlD
